Cargando…
Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation
BACKGROUND: Hepatocellular carcinoma (HCC) has high incidence and mortality worldwide. Local ablation using radiofrequency ablation (RFA) or microwave ablation (MWA) is potentially curative for early-stage HCC with outcomes comparable to surgical resection. We explored the influence of demographic,...
Autores principales: | Ali, Mohamed Abdulwahab Mohamed, Harmsen, William Scott, Morsy, Khairy Hammam, Galal, Ghada Moustapha Kamal, Therneau, Terry M., Roberts, Lewis Rowland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887142/ https://www.ncbi.nlm.nih.gov/pubmed/35227234 http://dx.doi.org/10.1186/s12885-021-09121-8 |
Ejemplares similares
-
3437 Associations of aspirin, non-aspirin NSAIDs, statins, and metformin with risk of biliary cancer: A Swedish population-based cohort study
por: Bonilla, Lorena Marcano, et al.
Publicado: (2019) -
Hypothyroidism is associated with worse outcomes of hepatocellular carcinoma patients after liver transplantation
por: Zhang, Ning, et al.
Publicado: (2018) -
Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models
por: Wongjarupong, Nicha, et al.
Publicado: (2018) -
The role of serum visfatin and vaspin in hepatocellular carcinoma in hepatitis C-related liver cirrhosis
por: Abdelhamed, Walaa, et al.
Publicado: (2023) -
Assessment of fibroblast growth factor 19 as a non-invasive serum marker for hepatocellular carcinoma
por: Mohamed, Ghada Abdelrahman, et al.
Publicado: (2022)